Urocortin II treatment reduces skeletal muscle mass and function loss during atrophy and increases nonatrophying skeletal muscle mass and function. (Q51827509)
Jump to navigation
Jump to search
scientific article published on 31 July 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Urocortin II treatment reduces skeletal muscle mass and function loss during atrophy and increases nonatrophying skeletal muscle mass and function. |
scientific article published on 31 July 2003 |
Statements
Urocortin II treatment reduces skeletal muscle mass and function loss during atrophy and increases nonatrophying skeletal muscle mass and function. (English)
1 reference
Richard T Hinkle
1 reference
Elizabeth Donnelly
1 reference
David B Cody
1 reference
Mary Beth Bauer
1 reference
Robert J Isfort
1 reference
31 July 2003
1 reference
144
1 reference
11
1 reference
4939-4946
1 reference
Identifiers
1 reference